RecruitingNot ApplicableNCT07390071

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy


Sponsor

University of Utah

Enrollment

40 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The proposed multimodal telerehabilitation model allows a rehabilitation therapy team to set up individualized rehabilitation plans using a web-based care management portal and monitor patient progress online. Patients at home follow a safe and effective personalized exercise and nutrition plan guided by interactive touch-screen technology combined with behavioral counseling, social support, and interactive education and empowerment. The design of the telerehabilitation system is based on the cloud-based Internet-of-Things architecture allowing real-time monitoring of cardiovascular parameters and exercise performance. The patient's level of exertion during exercise is automatically identified by a validated AI-driven algorithm supporting exercise safety and efficacy. The ultimate goal of this pilot feasibility project is to establish the extent of the impact of the proposed patient-centered cancer telerehabilitation model on disease-specific quality of life, and functional and symptom outcomes and to obtain sufficient evidence for a definitive randomized clinical trial evaluating this approach in a multi-center study.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing a telerehabilitation program (remote exercise and wellness coaching by phone) for people with lymphoma or myeloma who are about to receive CAR-T cell therapy — a type of advanced immunotherapy. The goal is to help patients stay stronger and recover better during and after treatment. **You may be eligible if...** - You are older than 21 - You have been diagnosed with lymphoma or myeloma - You are scheduled to receive a commercial, FDA-approved CAR-T cell therapy at least 4 weeks from now - You have access to a working phone at home - Your general health is reasonably good (ECOG score 0–2) **You may NOT be eligible if...** - You have unstable heart problems (e.g., recent heart attack, uncontrolled high blood pressure, pacemaker) - You have painful or unstable bone disease or recent bone fractures - You are already in a regular exercise rehabilitation program - You are enrolled in another clinical trial - You plan to relocate within the next 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHome Automated Telemanagement (HAT) Patient Unit

HAT (Home Automated Telemanagement) patient unit will guide patients in following their treatment plans, including exercise and diet prescriptions, monitor patients' progress and symptoms, and communication with health care providers. Participants will receive an internet-enabled device, either a touchscreen tablet or a virtual reality (VR) headset, as part of the patient unit, based on their personal preference. Participants will also be provided a pulse oximeter to monitor their heart rate and oxygen saturation, and a fitbit to assess daily physical activity and step counts.


Locations(1)

Huntsman Cancer Institute at University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07390071


Related Trials